New drug combo shows promise for tough lung cancer
NCT ID NCT04665856
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 27 times
Summary
This study tests whether adding the drug tiragolumab to standard treatment (atezolizumab plus chemotherapy) helps people with untreated extensive-stage small cell lung cancer live longer without their cancer growing. About 123 participants in China will receive either the new combo or a placebo plus standard treatment. The goal is to see if the extra drug improves progression-free and overall survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMALL CELL LUNG CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Beijing Cancer Hospital
Beijing, 100142, China
-
Beijing Chest Hospital
Beijing, 101149, China
-
Cancer Center of Guangzhou Medical University
Guangzhou, 510000, China
-
Cancer Hospital of Shantou University Medical College
Shantou, 515041, China
-
Fudan University Shanghai Cancer Center
Shanghai, 200120, China
-
Fujian Provincial Cancer Hospital
Fuzhou, 350014, China
-
Harbin Medical University Cancer Hospital
Harbin, 150081, China
-
Henan Cancer Hospital
Zhengzhou, 450008, China
-
Shanghai Chest Hospital
Shanghai, 200000, China
-
Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
Hangzhou, 310016, China
-
The 1st Affiliated Hospital of Nanchang Unversity
Nanchang, 330006, China
-
Wuhan Union Hospital Tongji Medical College, Huazhong University of Science and Technology
Wuhan, 430022, China
-
Zhejiang Cancer Hospital
Hangzhou, 310022, China
-
Zhongshan Hospital Fudan University
Shanghai, 200032, China
-
the First Affiliated Hospital of Bengbu Medical College
Bengbu, 233000, China
-
the First Hospital of Jilin University
Changchun, 130021, China
Conditions
Explore the condition pages connected to this study.